[ad_1]
The “Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report by Technology, by Delivery Mode, by Production Technology, by Material, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.
The global ophthalmic drug delivery systems market size is projected to reach USD 23.4 billion by 2030. The market is expected to expand at a CAGR of 8.3% from 2022 to 2030.
Companies Mentioned
-
Ocular Therapeutix Inc
-
Allergan plc.
-
Santen Pharmaceutical Co. Ltd.
-
Envisia Therapeutics
-
pSivida
-
Clearside Biomedical
-
Oculis Pharma
-
Valeant Pharmaceuticals
-
Aptar Group, Inc.
Factors such as growing prevalence of ophthalmic diseases, rise in number of ophthalmic procedures that require attentive post procedural care and increase in need to deliver controlled dosage forms for pediatric and geriatric population are anticipated to propel the growth of the market.
In addition, immense focus on technological advancements is further helping the market to grow at a significant rate. For instance, manufacturers’ instant focus on nanotechnology has helped to deliver error-free drug delivery and increase the penetration level of the drug at the target site .
The market observed a sudden fall in sales of ophthalmic drug delivery systems during the first half of the COVID-19 pandemic. The lockdowns across different countries and various restrictions led down by the government led to fall in number of patients’ visits to the hospitals and …
Full story available on Benzinga.com
[ad_2]
Source link
